Deloitte acquires disease surveillance business

Deloitte has acquired a disease surveillance business to aid in the consulting and professional services firm's push for growth in its public health transformation line of work.

CasePointer was stood up by End Point in 2008 as a developer of open source software to help public health agencies work with epidemiological data.

Now as part of Deloitte, the CasePointer team of technologists and public health specialists will work with clients on their modernization and surveillance needs. Terms of the transaction announced Tuesday were not disclosed.

Deloitte will look to combine its GovConnect digital assets with CasePointer's suite of tools that include the EpiTrax platform for collecting, organizing and maintaining data on diseases and other health hazards.

This move comes in the wake of Deloitte's acquisition in April of Gryphon Scientific, another public health-focused company but with a specialty in helping agencies use artificial intelligence and data to respond to infectious diseases.

“The acquisition of End Point’s CasePointer business builds on Deloitte’s ongoing investments, complements our customizable and human-centered solutions, and supports our growth into new markets,” Jason Salzetti, leader of Deloitte's government and public services practice, said in a release.

One example of those investments involves Deloitte's expansion of its generative artificial intelligence tools for health and human services agencies. First announced in September 2023, the firm is looking to help its state and local government clients streamline how they provide benefits and other services to citizens.